Synthetic Biologics Inc. (SYN) Soars 5.43% on December 25

Equities Staff  |

Synthetic Biologics Inc. (SYN) had a good day on the market for Friday December 25 as shares jumped 5.43% to close at $0.38. About 1.15 million shares traded hands on 1,642 trades for the day, compared with an average daily volume of n/a shares out of a total float of 19.99 million. After opening the trading day at $0.38, shares of Synthetic Biologics Inc. stayed within a range of $0.38 to $0.37.

With today's gains, Synthetic Biologics Inc. now has a market cap of $7.54 million. Shares of Synthetic Biologics Inc. have been trading within a range of $0.75 and $0.26 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.

Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbiome from the effects of regularly used intravenous drugs for the prevention of C. difficile infection, antibiotic-associated diarrhea, and the emergence of antibiotic-resistant organisms. The company is also developing monoclonal antibody therapies for the treatment of pertussis and novel discovery-stage biotherapeutics for the treatment of phenylketonuria.

Synthetic Biologics Inc. is based out of Rockville, MD and has some 11 employees. Its CEO is Steven A. Shallcross.

For a complete fundamental analysis of Synthetic Biologics Inc., check out’s Stock Valuation Analysis report for SYN.

Still paying commissions on stock trades? now offers $7.99/month unlimited trading and flat-fee options trading for $89.99/month! Get started today by

Synthetic Biologics Inc. is also a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

To get more information on Synthetic Biologics Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: SYN’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Market Movers

Sponsored Financial Content